Therapeutic Effectiveness of Vardenafil in ED Patients With the Metabolic Syndrome in Daily Clinical Practice.

Trial Profile

Therapeutic Effectiveness of Vardenafil in ED Patients With the Metabolic Syndrome in Daily Clinical Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2014

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms REVITALISE
  • Sponsors Bayer
  • Most Recent Events

    • 20 Feb 2013 Actual initiation date changed from Feb 2010 to May 2010 as reported by ClinicalTrials.gov.
    • 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Aug 2012 Planned end date changed from 1 Jun 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top